persimmune.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title PersImmune, Inc. – Personalized Adoptive T-Cell
Description The Future of Immunotherapy is Technology News About Investor Portal Contact The Future of Immunotherapy is Personal Personalized Adoptive Cellular Therapy Targeting Neoantigens A new a
Keywords N/A
Server Information
WebSite persimmune faviconpersimmune.com
Host IP 209.59.166.76
Location United States
Related Websites
Site Rank
More to Explore
persimmune.com Valuation
US$2,970,703
Last updated: 2023-05-06 23:06:08

persimmune.com has Semrush global rank of 3,562,896. persimmune.com has an estimated worth of US$ 2,970,703, based on its estimated Ads revenue. persimmune.com receives approximately 342,774 unique visitors each day. Its web server is located in United States, with IP address 209.59.166.76. According to SiteAdvisor, persimmune.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,970,703
Daily Ads Revenue US$2,743
Monthly Ads Revenue US$82,266
Yearly Ads Revenue US$987,188
Daily Unique Visitors 22,852
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
persimmune.com. A 3600 IP: 209.59.166.76
persimmune.com. NS 7200 NS Record: ns9.worldnic.com.
persimmune.com. NS 7200 NS Record: ns10.worldnic.com.
persimmune.com. MX 7200 MX Record: 10 mx1.netsolmail.net.
persimmune.com. TXT 3600 TXT Record: google-site-verification=b_ULgJm_wT6sFQR0gY6zv9DSNpZjob8P4nUoJXVAH10
persimmune.com. TXT 3600 TXT Record: MS=ms53311639
HtmlToTextCheckTime:2023-05-06 23:06:08
Technology News About Investor Portal Contact The Future of Immunotherapy is Personal Personalized Adoptive Cellular Therapy Targeting Neoantigens A new approach to immunotherapy PersImmune is a clinical-stage immunotherapy company whose mission is to provide cancer patients with optimized immunotherapy that is personalized on the basis of their own unique tumor signature . Just as no two people are alike, no two cancers are exactly alike; because of this, the same immunotherapy treatment that works for one patient may not work well in another. To address this treatment disparity, PersImmune’s proprietary protocol, Personal Adoptive Cellular Therapy for Neoantigens (PACTN) identifies the DNA alterations present in the cancer cells of each patient and generates enriched, tested, highly-specific T-cells that effectively kill the patient’s tumor cells. These are the patient’s own cells, and are not edited or genetically engineered which means patients will experience far less side
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 26 Oct 2021 22:06:38 GMT
Server: Apache
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: https://persimmune.com/
Cache-Control: max-age=600
Expires: Tue, 26 Oct 2021 22:16:38 GMT
Vary: User-Agent
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
cache-control: max-age=600
expires: Tue, 26 Oct 2021 22:16:40 GMT
vary: User-Agent
content-type: text/html; charset=UTF-8
date: Tue, 26 Oct 2021 22:06:40 GMT
server: Apache
persimmune.com Whois Information
Domain Name: PERSIMMUNE.COM
Registry Domain ID: 1598479498_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-05-22T14:50:51Z
Creation Date: 2010-05-22T00:42:41Z
Registry Expiry Date: 2022-05-22T00:42:41Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS10.WORLDNIC.COM
Name Server: NS9.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T21:17:26Z <<<

Copyright © 2022 WebZZ.US 0.0229